Efficacy and toxicity of neoadjuvant chemotherapy versus chemo-immunotherapy in triple-negative breast cancer patients with and without germline BRCA mutations.

Breast Cancer Res Treat · 2026 · PMC13287100 · PMID 42329463

Europe PMC DOI

hedged sentence

0.1180

closest p · 2.4× alpha

0.1180

boldest claim

The sentences

did not reach statistical significancep = 0.118not close (p > 0.1)

While the pathologic response of the primary tumor also varied significantly across these cohorts ( p = 0.004), the pathologic nodal response did not reach statistical significance ( p = 0.118).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.